title: Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma.
abstract: Promoter methylation of tumor suppressor gene SOX11 has been reported to contribute to the diagnosis and prognosis of various cancerous diseases, including gastric cancer, hematopoietic malignancies and nasopharyngeal carcinoma. However, there is no data on the diagnostic potential of serum SOX11 promoter methylation in hepatocellular carcinoma (HCC). This study was therefore aimed to investigate the potential role of serum SOX11 promoter methylation as a noninvasive biomarker in the diagnosis of patients with hepatitis B virus (HBV) associated HCC. A total of 205 subjects were retrospectively included, which consisted of 111 HCC patients, 66 chronic hepatitis B (CHB) and 28 healthy controls (HCs). Methylation of SOX11 promoter was determined by methylation-specific polymerase chain reaction. The methylation frequency of serum SOX11 promoter in HCC patients (69.4%, 77/111) was significantly higher than that in CHB patients (13.6%, 9/66; χ2 = 51.467, P<0.001) and HCs (10.7%, 3/28; χ2 = 31.489, P<0.001). There was significant difference of serum SOX11 promoter methylation in HCC patients with vascular invasion (49/58) and those without vascular invasion (28/53; χ2 = 13.058, P<0.001). Furthermore, the sensitivity of 69% was identified for SOX11 methylation in discriminating HCC from CHB, which was significant higher than the sensitivity of 57% for serum alpha-fetoprotein (AFP) (P<0.05). Notably, SOX11 promoter methylation plus AFP showed a sensitivity of 85% in discriminating HCC from CHB. These results suggested that serum SOX11 promoter methylation might serve as a useful and noninvasive biomarker for the diagnosis of HCC.
authors.forename: Y
authors.initials: Y
authors.lastname: Teng
authors.forename: Y C
authors.initials: YC
authors.lastname: Fan
authors.forename: N N
authors.initials: NN
authors.lastname: Mu
authors.forename: J
authors.initials: J
authors.lastname: Zhao
authors.forename: F K
authors.initials: FK
authors.lastname: Sun
authors.forename: K
authors.initials: K
authors.lastname: Wang
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000235:genetics / Q000821:virology*; D016022:Case-Control Studies; D019175:DNA Methylation; D003937:Diagnosis, Differential; D005260:Female; D006515:Hepatitis B virus / Q000302:isolation & purification; D019694:Hepatitis B, Chronic / Q000097:blood* / Q000235:genetics; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood / Q000235:genetics / Q000821:virology*; D008297:Male; D008875:Middle Aged; D011401:Promoter Regions, Genetic; D012189:Retrospective Studies; D055751:SOXC Transcription Factors / Q000097:blood* / Q000235:genetics; D000509:alpha-Fetoproteins / Q000378:metabolism
chemical_list: C097473:SOX11 protein, human; D055751:SOXC Transcription Factors; D000509:alpha-Fetoproteins
keywords: DNA methylation; SOX11; biomarker; hepatocellular carcinoma.; serum